Journal of Experimental Therapeutics and Oncology
Journal of Experimental Therapeutics and Oncology is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 40. It has an SJR impact factor of 0,108 and it has a best quartile of Q4. It is published in English. It has an SJR impact factor of 0,108.
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
0,108
H-index
40
Docs (year)
0
Docs 3y
5
Total refs
0
Cites 3y
0
Citable 3y
4
Cites/Doc 2y
0
Ref/Doc
0.0
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Murine pharmacokinetics and metabolism of oleandrin, a cytotoxic component of Nerium oleander
View moreType-1 transforming growth factor-beta differentially modulates tumoricidal activity of murine peritoneal macrophages against metastatic variants of the B16 murine melanoma
View moreSubcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters
View moreVanadium suppresses sister-chromatid exchange and DNA-protein crosslink formation and restores antioxidant status and hepatocellular architecture during 2-acetylaminofluorene-induced experimental rat hepatocarcinogenesis
View moreUse of microdialysis to study platinum anticancer agent pharmacokinetics in preclinical models
View moreTissue reactions after long-term intracerebral implantation of three different types of biodegradable polylactide rods in the rat
View moreThe reversal of multidrug resistance: an update
View moreSuperinduction of P-glycoprotein messenger RNA in vivo in the presence of transcriptional inhibitors
View moreTitle: Natural Compounds in Cancer Therapy Author: John Boik
View moreParameters affecting the ex vivo cytotoxic drug sensitivity of human hematopoietic cells
View morep53 Expression, growth, and spontaneous metastasis of the human GI 101 breast carcinoma in athymic nude mice
View moreP-glycoprotein expression by cancer cells affects cell cytotoxicity and cell-cycle perturbations induced by six chemotherapeutic drugs
View morePhosphatidylcholine-derived phosphatidic acid and diacylglycerol are involved in the signaling pathways activated by docetaxel
View moreModulation of resistance to idarubicin by the cyclosporin PSC 833 (valspodar) in multidrug-resistant cells
View moreModulation of antineoplastic activity of cyclophosphamide by Alstonia scholaris in the Ehrlich ascites carcinoma-bearing mice
View moreLymphocyte activation by granulocyte macrophage-colony stimulating factor in human bladder cancer
View moreLow-dose total body irradiation augments the therapeutic effect of interleukin-2 in a mouse model for metastatic malignant melanoma
View moreLoss of heterozygosity and microsatellite instability in epithelial hyperplasia of the breast
View moreLoss of growth factor sensitivity and development of mitoxantrone resistance in transplanted recurrent SA7HD myeloid leukaemia
View moreLocal administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice
View moreLaser-assisted microdissection applied to frozen surgical pathologic specimens - methodological aspects on RT-PCR
View moreLack of toxicity of EGFR antisense gene therapy
View moreInterleukin-1alpha increases the cytotoxic activity of etoposide against human osteosarcoma cells
View moreInhibitory effect of vitamin D3 on 3'methyl-4-dimethyl-amino-azobenzene-induced rat hepatocarcinogenesis: a study on Antioxidant Defense Enzymes
View more